Get started
Virtus LifeSci Biotech Clinical Trials ETF logo

BBC

ETFNASDAQ

Virtus LifeSci Biotech Clinical Trials ETF

BBC is an ETF, not a company. An exchange-traded fund holds a basket of assets and trades like a stock.

Follow + get alerts

Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund (ETF) listed on NASDAQ. There were no new wire items for BBC in the last 30 days. The most recent was published May 16, 2024.

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Latest news

1 item

BBC FAQ

7 questions
  • What does Virtus LifeSci Biotech Clinical Trials ETF do?
    The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
  • What is the latest news on BBC?
    Quantisnow has not tracked any new filings, ratings or press releases for BBC in the last 30 days. The most recent wire item was published on May 16, 2024.
  • Where does BBC stock trade?
    Virtus LifeSci Biotech Clinical Trials ETF (BBC) is listed on NASDAQ.
  • What sector and industry is BBC in?
    Virtus LifeSci Biotech Clinical Trials ETF operates in the n/a sector.
  • When did Virtus LifeSci Biotech Clinical Trials ETF go public?
    Virtus LifeSci Biotech Clinical Trials ETF (BBC) completed its IPO in n/a.
  • What companies are similar to BBC?
    Notable peers in the same industry include HCXY (Hercules Capital, Inc.), ACCP (Accelerated Pharma, Inc.), ACLL (ACell, Inc.), DWEQ (AdvisorShares Dorsey Wright Alpha Equal Weight ETF), DWAW (AdvisorShares Dorsey Wright FSM All Cap World ETF). Compare BBC side-by-side with any of them on Quantisnow.
  • How can I track BBC on Quantisnow?
    Quantisnow aggregates Virtus LifeSci Biotech Clinical Trials ETF's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BBC to receive live email and push alerts on every new disclosure.